vindicocme.com/100517 tm vindico/media/vmemeetingsites/2017/infectiousdise… · 6900 grove road...

6900 Grove Road • Building 100Thorofare, NJ 08086-9447

VINDICOmedical education

PresortedFirst Class Mail

US PostagePAID

Permit # 906Bellmawr NJ

CASE CHOICE

CASE CHOICE

InteractIve DInner SympoSIum


Hot topics in

Hot topics in

HiV ManageMent

HiV ManageMent

Y o u P i c k t h e c a s e


thursday, october 5, 2017Marriott Marquis san Diego Marina Marriott Grand Ballroom sections 1-6 Lobby Level, North tower | san Diego, ca


5:30 pm – 6:00 pm Registration and Dinner6:00 pm – 8:00 pm cMe/cpe-certified activity


Activity Chairpaul e. sax, MD

FacultyRichard a. elion, MD Joseph J. eron, Jr., MDBabafemi o. taiwo, MBBs

RegisteR online! VindicoCME.com/100517


This activity is supported by an educational grant from

ViiV Healthcare.

This activity is not affiliated with the official program of

IDWeek 2017TM.VINDICOmedical education

This continuing pharmacy education activity is provided by

This continuing medical education activity is provided by

CMECPE

2.0

paul e. sax, MDClinical Director, Division of Infectious DiseasesBrigham and Women’s HospitalProfessor of MedicineHarvard Medical SchoolBoston, MA

Richard a. elion, MD Clinical Professor of MedicineGeorge Washington University School of MedicineCo-DirectorHIV/HCV Treatment and Research Program Providence Hospital Washington, DC

Joseph J. eron, Jr., MDProfessor of Medicine Division of Infectious DiseasesUniversity of North Carolina at Chapel Hill School of MedicineChapel Hill, NC

Babafemi o. taiwo, MBBsProfessor of MedicineChief, Division of Infectious DiseasesNorthwestern University Feinberg School of MedicineChicago, IL

Activity Chair Faculty


ADA compliance: In compliance with the Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests.

First Name ______________________________ M.I._______ Last Name _________________________________________

Preferred Mailing Address (Home/Business) ___________________________________________________________________

______________________________________________________________________________________________________

City ___________________________ State_______ Zip Code ______________ Country ____________________________

Daytime Phone _______________________________________ Evening Phone ______________________________________

Fax ____________________________ E-mail ______________________________________ Date of Birth _______________

National Provider Identifier (NPI)_______________ Medical License Number______________ Medical License State____________

(for confirmation purposes) (for confirmation purposes) (for tracking credits ONLY)

How did you hear about this meeting?(multiple selections allowed)q Advertisement q Brochure

q E-mailq Postcard

q Web siteq Word of mouth

Specialty (select one)q Infectious Diseaseq Internal Medicineq HIV/AIDS

Degree (please specify)q MD/DOq PhDq MD, PhD

q PharmD/RPhq PAq RN/BSN/MSN

q NPq Industryq Other:_______

CME/CPE Activity Requestq YES, I would like to receive information regarding future

CME/CPE activities related to this therapeutic area.

Priority Code: 255 - 1 2 3

Contact Information:E-mail: [email protected]

Toll-free: 877-307-5225, ext. 219 or 476

Phone: 856-994-9400, ext. 219 or 476

Fax: 856-251-0278

Mail: Registration Department 6900 Grove Road Thorofare, NJ 08086-9447

q Pharmacyq Other:___________


thursday, october 5, 2017Marriott Marquis san Diego Marina Marriott Grand Ballroom sections 1-6 Lobby Level, North tower san Diego, ca


AgendaOverviewantiretroviral therapy has improved dramatically over the past decade. this progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of HiV. clinicians must keep up with new data on treatment strategies, selection of appropriate individualized therapy, and effective management of patient side effects. in this interactive, case-based program, expert faculty will convey how to incorporate new treatment strategies into clinical practice and discuss various aspects of HiV management, including selecting an initial antiretroviral regimen, modifying therapy in virologically suppressed patients, and selecting the optimal approach for those with treatment failure.

Learning ObjectivesUpon successful completion of this activity, participants should be better able to:

• Applyupdatedevidence-basedguidelinesandrecommendations when selecting initial treatment for patients with HiV.

• SelectandoptimizeHIVtreatmentregimens based on clinical safety and efficacy, propensity for resistance, and patient characteristics.

• ConsiderpatientpreferenceswhenselectingHIVtreatment regimens to increase adherence and compliance to therapy.

• Implementeffectiveswitchingstrategies,asnecessary, in patients who are virologically suppressed, have become virologically resistant to therapy, or have become nonadherent.

Target Audiencethe intended audience for this activity is infectious disease specialists, HiV treaters, pharmacists, and other health care professionals involved in the treatment of patients with HiV.

5:30 pm – 6:00 pm Registration and Dinner

6:00 pm – 6:10 pm introduction and pretest Paul E. Sax, MD

6:10 pm – 6:30 pm What’s new in HiV treatment: Finding the Best options

Paul E. Sax, MD

6:30 pm – 6:45 pm Determining the Most

appropriate initial treatment Richard A. Elion, MD

6:45 pm – 6:50 pm Question and answer

6:50 pm – 7:05 pm switching aRt in Virologic

suppression Babafemi O. Taiwo, MBBS


7:10 pm – 7:25 pm

Managing treatment - experienced HiV patients with Virologic Failure

Joseph J. Eron, Jr., MD


7:30 pm – 7:45 pm panel Discussion

7:45 pm – 8:00 pm posttest and Question and answer

8:00 pm Meeting adjournment


CASE CHOICE InteractIve DInner SympoSIum

Hot topics inHiV ManageMentY o u P i c k t h e c a s e

CMECPE

2.0

CASE CHOICE

CASE CHOICE

CASE CHOICE

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This program is acceptable for 2.0 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-17-004-L02-P, effective 10/5/2017. This is an application-based activity and there is no fee to attend.

To receive credit, physicians and pharmacists must attend the entire presentation and complete the evaluation at the end of the program. Credit Claim Forms will be available onsite.

In accordance with the Accreditation Council for Continuing Medical Education and Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all planners, speakers, reviewers, and staff involved in the development of CME/CPE content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

Customized learning at your fingertips – you choose the case!

Audience-driven, Case-based Learning

CASE CHOICE

© 2

017

iSto

ckph

oto.

com

/bill

noll;

Ezu

meI

mag

es




US PostagePAID


CASE CHOICE

CASE CHOICE



Hot topics in

Hot topics in

HiV ManageMent

HiV ManageMent












ViiV Healthcare.





CMECPE

2.0







ADA compliance: In compliance with the Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests.

First Name ______________________________ M.I._______ Last Name _________________________________________

Preferred Mailing Address (Home/Business) ___________________________________________________________________

______________________________________________________________________________________________________

City ___________________________ State_______ Zip Code ______________ Country ____________________________

Daytime Phone _______________________________________ Evening Phone ______________________________________

Fax ____________________________ E-mail ______________________________________ Date of Birth _______________

National Provider Identifier (NPI)_______________ Medical License Number______________ Medical License State____________

(for confirmation purposes) (for confirmation purposes) (for tracking credits ONLY)

How did you hear about this meeting?(multiple selections allowed)q Advertisement q Brochure

q E-mailq Postcard

q Web siteq Word of mouth

Specialty (select one)q Infectious Diseaseq Internal Medicineq HIV/AIDS

Degree (please specify)q MD/DOq PhDq MD, PhD

q PharmD/RPhq PAq RN/BSN/MSN

q NPq Industryq Other:_______

CME/CPE Activity Requestq YES, I would like to receive information regarding future

CME/CPE activities related to this therapeutic area.

Priority Code: 255 - 1 2 3

Contact Information:E-mail: [email protected]

Toll-free: 877-307-5225, ext. 219 or 476

Phone: 856-994-9400, ext. 219 or 476

Fax: 856-251-0278

Mail: Registration Department 6900 Grove Road Thorofare, NJ 08086-9447

q Pharmacyq Other:___________


thursday, october 5, 2017Marriott Marquis san Diego Marina Marriott Grand Ballroom sections 1-6 Lobby Level, North tower san Diego, ca


AgendaOverviewantiretroviral therapy has improved dramatically over the past decade. this progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of HiV. clinicians must keep up with new data on treatment strategies, selection of appropriate individualized therapy, and effective management of patient side effects. in this interactive, case-based program, expert faculty will convey how to incorporate new treatment strategies into clinical practice and discuss various aspects of HiV management, including selecting an initial antiretroviral regimen, modifying therapy in virologically suppressed patients, and selecting the optimal approach for those with treatment failure.

Learning ObjectivesUpon successful completion of this activity, participants should be better able to:

• Applyupdatedevidence-basedguidelinesandrecommendations when selecting initial treatment for patients with HiV.

• SelectandoptimizeHIVtreatmentregimens based on clinical safety and efficacy, propensity for resistance, and patient characteristics.

• ConsiderpatientpreferenceswhenselectingHIVtreatment regimens to increase adherence and compliance to therapy.

• Implementeffectiveswitchingstrategies,asnecessary, in patients who are virologically suppressed, have become virologically resistant to therapy, or have become nonadherent.

Target Audiencethe intended audience for this activity is infectious disease specialists, HiV treaters, pharmacists, and other health care professionals involved in the treatment of patients with HiV.

5:30 pm – 6:00 pm Registration and Dinner

6:00 pm – 6:10 pm introduction and pretest Paul E. Sax, MD

6:10 pm – 6:30 pm What’s new in HiV treatment: Finding the Best options

Paul E. Sax, MD

6:30 pm – 6:45 pm Determining the Most

appropriate initial treatment Richard A. Elion, MD


6:50 pm – 7:05 pm switching aRt in Virologic

suppression Babafemi O. Taiwo, MBBS


7:10 pm – 7:25 pm

Managing treatment - experienced HiV patients with Virologic Failure

Joseph J. Eron, Jr., MD


7:30 pm – 7:45 pm panel Discussion

7:45 pm – 8:00 pm posttest and Question and answer

8:00 pm Meeting adjournment


CASE CHOICE InteractIve DInner SympoSIum

Hot topics inHiV ManageMentY o u P i c k t h e c a s e

CMECPE

2.0

CASE CHOICE

CASE CHOICE

CASE CHOICE

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This program is acceptable for 2.0 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-17-004-L02-P, effective 10/5/2017. This is an application-based activity and there is no fee to attend.

To receive credit, physicians and pharmacists must attend the entire presentation and complete the evaluation at the end of the program. Credit Claim Forms will be available onsite.

In accordance with the Accreditation Council for Continuing Medical Education and Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all planners, speakers, reviewers, and staff involved in the development of CME/CPE content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

Customized learning at your fingertips – you choose the case!

Audience-driven, Case-based Learning

CASE CHOICE

© 2

017

iSto

ckph

oto.

com

/bill

noll;

Ezu

meI

mag

es




US PostagePAID


CASE CHOICE

CASE CHOICE



Hot topics in

Hot topics in

HiV ManageMent

HiV ManageMent












ViiV Healthcare.





CMECPE

2.0







vindicocme.com/100517 tm vindico/media/vmemeetingsites/2017/infectiousdise… · 6900 grove road...

Documents